In today’s rapidly evolving healthcare landscape, having timely and reliable market insights is essential. Yet, many regions remain underserved, leaving pharmaceutical companies and healthcare providers with incomplete information. APLUSA bridges this gap by delivering high-quality market research in niche regions, enabling data-driven decisions even where insights are scarce.
Key Findings from Turkey
One example is the multiple myeloma market in Turkey, where historical data has been limited. APLUSA’s recent study highlights several key findings that are critical for understanding treatment dynamics in this region.
- Limited Novel Treatment Options: Compared to better-served regions such as the EU5, the USA, and Japan, Turkey has fewer access points to novel therapies. This limitation impacts treatment patterns and patient outcomes.
- Patient Demographics: The average age of patients in Turkey is 60, compared to the EU5 average of 70 years. This demographic difference influences treatment decisions and disease management strategies.
- Treatment Patterns: The data shows that the vast majority of patients in Turkey are treated with stem-cell therapy. Given the limited access to novel options, stem-cell treatment provides a powerful first-line solution for managing multiple myeloma.
Comprehensive Research Methodology
Fieldwork was carried out in Q3, sampling 50 hematologists across a variety of institutions and analyzing over 500 patient charts. This robust dataset allows for a clear, actionable understanding of the multiple myeloma landscape across Turkey.
Global Reach, Local Expertise
APLUSA’s expertise isn’t limited to Turkey. The company has successfully delivered market research across 70+ regions. By combining local insights with global experience, APLUSA ensures that clients receive data that is both accurate and strategically relevant, no matter the region.
Why This Matters
For stakeholders exploring niche markets, high-quality research is key to identifying opportunities, optimizing launches, and making evidence-based decisions. With APLUSA, even markets that were previously underserved, like Turkey for multiple myeloma, are now accessible. This positions clients to act ahead of competitors and shape strategies based on real-world evidence rather than assumptions.
Unlock Insights in Underserved Markets
APLUSA is committed to providing high-quality market research where it is needed most. For pharmaceutical companies looking to understand patient demographics, treatment trends, and market potential in regions traditionally overlooked, our niche market research solutions deliver the clarity and confidence required to act decisively.
